What is the recommended administration schedule and contraindications for the Measles, Mumps, and Rubella (MMR) vaccine in pediatric and adult patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MMR Vaccine: Administration Schedule and Contraindications

All children should receive two doses of MMR vaccine: the first dose at 12-15 months of age and the second dose at 4-6 years of age before school entry, with a minimum interval of 4 weeks between doses. 1, 2

Pediatric Vaccination Schedule

First Dose Timing

  • Administer the first dose at 12-15 months of age as part of routine childhood immunization 3, 1, 2
  • The minimum age for MMR vaccination is 12 months 1
  • In high-risk areas (large inner city populations, recent outbreaks, or >5 cases among preschoolers in the last 5 years), administer as early as 12 months 3

Second Dose Timing

  • Routinely administer the second dose at 4-6 years of age (before kindergarten or first grade entry) 3, 1, 2
  • The second dose may be given earlier than 4 years, provided at least 4 weeks have elapsed since the first dose 1, 2
  • This timing was jointly adopted by ACIP, AAP, and AAFP to reduce primary vaccine failure, which occurs in approximately 5% of children receiving only one dose 3

Catch-Up Vaccination

  • Children who missed their scheduled doses should receive 2 doses with a minimum 4-week interval, regardless of current age or time elapsed 1
  • Never restart the vaccine series—continue where you left off 1
  • For adolescents aged 11-12 years without documentation of two doses, administer MMR vaccine during the routine health maintenance visit 3

Adult Vaccination

General Adult Recommendations

  • Adults born in 1957 or later without documentation of vaccination or immunity should receive at least one dose of MMR vaccine 2
  • Most persons born before 1957 are presumed immune due to natural infection, though this does not guarantee immunity 3

High-Risk Adults Requiring Two Doses

  • Students attending colleges or post-high school educational institutions 4, 5
  • Healthcare personnel 4, 5
  • International travelers 4

MMRV Combination Vaccine Considerations

First Dose (Ages 12-47 Months)

  • Use separate MMR and varicella vaccines rather than MMRV for the first dose in children 12-47 months due to increased febrile seizure risk 1, 2
  • MMRV carries approximately one additional febrile seizure per 2,300-2,600 doses compared to separate vaccines in children aged 12-23 months 1
  • Either MMR plus separate varicella or MMRV may be used, but providers must discuss the increased seizure risk with parents/caregivers 1

Second Dose (Any Age)

  • MMRV is generally preferred over separate injections for the second dose at any age (15 months-12 years) 1, 2
  • For first doses at ≥48 months, MMRV is also preferred (the 47-month cutoff was selected because approximately 97% of febrile seizures occur in children ≤47 months) 1

Seizure History Precaution

  • A personal or family history (sibling or parent) of seizures of any etiology is a precaution for MMRV vaccination 1, 2
  • In these cases, use separate MMR and varicella vaccines instead 1, 2

Key Contraindications

Absolute Contraindications

  • Severe immunocompromise (MMR should not be administered to severely immunocompromised children) 1, 2
  • Pregnancy 2
  • Severe anaphylactic reaction to vaccine components 2
  • High-dose systemic corticosteroids 2

Special Populations

HIV-Infected Children

  • HIV-infected children should receive MMR vaccine at 12 months if not severely immunosuppressed 3
  • Asymptomatic HIV-infected children without severe immunosuppression should receive MMR as soon as possible upon reaching 12 months, and consider the second dose as early as 28 days after the first 1
  • Children with perinatal HIV infection who were vaccinated before effective antiretroviral therapy (ART) should be revaccinated with 2 appropriately spaced doses once effective ART is established 4

Administration Guidelines

Timing with Other Vaccines

  • MMR may be administered simultaneously with other vaccines 2
  • If not given simultaneously with other live vaccines, administer at least 28 days before or after another live vaccine 2
  • For varicella vaccine specifically, a minimum interval of 3 months is recommended when not given simultaneously 2

Minimum Intervals

  • The minimum interval between first and second MMR doses is 4 weeks 1, 2
  • For varicella vaccine in children 12 months-12 years, the minimum interval is 3 months 2
  • For adolescents and adults receiving varicella vaccine, the minimum interval is 4 weeks 2

Common Clinical Pitfalls to Avoid

  • Do not delay catch-up vaccination waiting for the "ideal" age—start immediately with a minimum 4-week interval 1
  • Do not restart the vaccine series if there's been a long gap—continue where you left off 1
  • Do not use MMRV reflexively for first doses in young children due to increased febrile seizure risk 1
  • Do not assume birth before 1957 guarantees immunity—during mumps outbreaks, consider MMR vaccination for exposed persons born before 1957 3

Safety Profile

Serious Adverse Events

  • Serious outcomes (anaphylaxis, encephalitis/myelitis, Guillain-Barré syndrome, immune thrombocytopenia, meningitis, seizure) are rare, with incidence ≤6 per 100,000 doses in adolescents and adults 6

Common Non-Serious Events

  • Arthropathy (263.0 per 100,000 doses), injection site reactions (157.0 per 100,000 doses), and rash (112.9 per 100,000 doses) are the most common non-serious outcomes 6
  • Counsel vaccinees regarding anticipated local and systemic adverse events 6

References

Guideline

MMR Vaccine Schedule Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

MMR and Varicella Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.